PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1989; 82(Suppl 17): 52–56.
PMCID: PMC1291942

Status of malaria vaccine research.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hockmeyer WT, Ballou WR. Sporozoite immunity and vaccine development. Prog Allergy. 1988;41:1–14. [PubMed]
  • Weber JL, Hockmeyer WT. Structure of the circumsporozoite protein gene in 18 strains of Plasmodium falciparum. Mol Biochem Parasitol. 1985 Jun;15(3):305–316. [PubMed]
  • Ballou WR, Hoffman SL, Sherwood JA, Hollingdale MR, Neva FA, Hockmeyer WT, Gordon DM, Schneider I, Wirtz RA, Young JF, et al. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet. 1987 Jun 6;1(8545):1277–1281. [PubMed]
  • Herrington DA, Clyde DF, Losonsky G, Cortesia M, Murphy JR, Davis J, Baqar S, Felix AM, Heimer EP, Gillessen D, et al. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature. 1987 Jul 16;328(6127):257–259. [PubMed]
  • Chen DH, Tigelaar RE, Weinbaum FI. Immunity to sporozoite-induced malaria infeciton in mice. I. The effect of immunization of T and B cell-deficient mice. J Immunol. 1977 Apr;118(4):1322–1327. [PubMed]
  • Good MF, Miller LH. Involvement of T cells in malaria immunity: implications for vaccine development. Vaccine. 1989 Feb;7(1):3–9. [PubMed]
  • Good MF, Berzofsky JA, Miller LH. The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development. Annu Rev Immunol. 1988;6:663–688. [PubMed]
  • Sinigaglia F, Guttinger M, Kilgus J, Doran DM, Matile H, Etlinger H, Trzeciak A, Gillessen D, Pink JR. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature. 1988 Dec 22;336(6201):778–780. [PubMed]
  • Good MF, Kumar S, Miller LH. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation. Immunol Today. 1988 Nov;9(11):351–355. [PubMed]
  • Romero PJ, Tam JP, Schlesinger D, Clavijo P, Gibson H, Barr PJ, Nussenzweig RS, Nussenzweig V, Zavala F. Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei. Eur J Immunol. 1988 Dec;18(12):1951–1957. [PubMed]
  • Good MF, Pombo D, Lunde MN, Maloy WL, Halenbeck R, Koths K, Miller LH, Berzofsky JA. Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2. J Immunol. 1988 Aug 1;141(3):972–977. [PubMed]
  • Hoffman SL, Oster CN, Mason C, Beier JC, Sherwood JA, Ballou WR, Mugambi M, Chulay JD. Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J Immunol. 1989 Feb 15;142(4):1299–1303. [PubMed]
  • Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci U S A. 1988 Jan;85(2):573–576. [PubMed]
  • Kumar S, Miller LH, Quakyi IA, Keister DB, Houghten RA, Maloy WL, Moss B, Berzofsky JA, Good MF. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature. 1988 Jul 21;334(6179):258–260. [PubMed]
  • Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, Nussenzweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 1987 Dec 17;330(6149):664–666. [PubMed]
  • Guerin-Marchand C, Druilhe P, Galey B, Londono A, Patarapotikul J, Beaudoin RL, Dubeaux C, Tartar A, Mercereau-Puijalon O, Langsley G. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature. 1987 Sep 10;329(6135):164–167. [PubMed]
  • Patarroyo ME, Amador R, Clavijo P, Moreno A, Guzman F, Romero P, Tascon R, Franco A, Murillo LA, Ponton G, et al. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature. 1988 Mar 10;332(6160):158–161. [PubMed]
  • Quakyi IA, Matsumoto Y, Carter R, Udomsangpetch R, Sjolander A, Berzins K, Perlmann P, Aikawa M, Miller LH. Movement of a falciparum malaria protein through the erythrocyte cytoplasm to the erythrocyte membrane is associated with lysis of the erythrocyte and release of gametes. Infect Immun. 1989 Mar;57(3):833–839. [PMC free article] [PubMed]
  • Collins WE, Anders RF, Pappaioanou M, Campbell GH, Brown GV, Kemp DJ, Coppel RL, Skinner JC, Andrysiak PM, Favaloro JM, et al. Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature. 1986 Sep 18;323(6085):259–262. [PubMed]
  • Wahlgren M, Björkman A, Perlmann H, Berzins K, Perlmann P. Anti-Plasmodium falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity. Am J Trop Med Hyg. 1986 Jan;35(1):22–29. [PubMed]
  • Holder AA. The precursor to major merozoite surface antigens: structure and role in immunity. Prog Allergy. 1988;41:72–97. [PubMed]
  • Perrin LH, Merkli B, Loche M, Chizzolini C, Smart J, Richle R. Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages. J Exp Med. 1984 Aug 1;160(2):441–451. [PMC free article] [PubMed]
  • Siddiqui WA, Tam LQ, Kramer KJ, Hui GS, Case SE, Yamaga KM, Chang SP, Chan EB, Kan SC. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc Natl Acad Sci U S A. 1987 May;84(9):3014–3018. [PubMed]
  • Holder AA, Freeman RR, Nicholls SC. Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Parasite Immunol. 1988 Nov;10(6):607–617. [PubMed]
  • Patarroyo ME, Romero P, Torres ML, Clavijo P, Moreno A, Martínez A, Rodríguez R, Guzman F, Cabezas E. Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature. 1987 Aug 13;328(6131):629–632. [PubMed]
  • Coppel RL, Cowman AF, Lingelbach KR, Brown GV, Saint RB, Kemp DJ, Anders RF. Isolate-specific S-antigen of Plasmodium falciparum contains a repeated sequence of eleven amino acids. Nature. 1983 Dec 22;306(5945):751–756. [PubMed]
  • McLean SA, Pearson CD, Phillips RS. Antigenic variation in Plasmodium chabaudi: analysis of parent and variant populations by cloning. Parasite Immunol. 1986 Sep;8(5):415–424. [PubMed]
  • Hommel M, Semoff S. Expression and function of erythrocyte-associated surface antigens in malaria. Biol Cell. 1988;64(2):183–203. [PubMed]
  • Weidanz WP, Long CA. The role of T cells in immunity to malaria. Prog Allergy. 1988;41:215–252. [PubMed]
  • Ockenhouse CF, Schulman S, Shear HL. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages. J Immunol. 1984 Sep;133(3):1601–1608. [PubMed]
  • Wozencraft AO, Dockrell HM, Taverne J, Targett GA, Playfair JH. Killing of human malaria parasites by macrophage secretory products. Infect Immun. 1984 Feb;43(2):664–669. [PMC free article] [PubMed]
  • Rockett KA, Targett GA, Playfair JH. Killing of blood-stage Plasmodium falciparum by lipid peroxides from tumor necrosis serum. Infect Immun. 1988 Dec;56(12):3180–3183. [PMC free article] [PubMed]
  • Waters LS, Taverne J, Tai PC, Spry CJ, Targett GA, Playfair JH. Killing of Plasmodium falciparum by eosinophil secretory products. Infect Immun. 1987 Apr;55(4):877–881. [PMC free article] [PubMed]
  • Riley EM, Jepsen S, Andersson G, Otoo LN, Greenwood BM. Cell-mediated immune responses to Plasmodium falciparum antigens in adult Gambians. Clin Exp Immunol. 1988 Mar;71(3):377–382. [PubMed]
  • Riley EM, Andersson G, Otoo LN, Jepsen S, Greenwood BM. Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. Clin Exp Immunol. 1988 Jul;73(1):17–22. [PubMed]
  • Clark IA. Cell-mediated immunity in protection and pathology of malaria. Parasitol Today. 1987 Oct;3(10):300–305. [PubMed]
  • Ho M, Webster HK. Immunology of human malaria. A cellular perspective. Parasite Immunol. 1989 Mar;11(2):105–116. [PubMed]
  • Carter R, Kumar N, Quakyi I, Good M, Mendis K, Graves P, Miller L. Immunity to sexual stages of malaria parasites. Prog Allergy. 1988;41:193–214. [PubMed]
  • Harte PG, Rogers N, Targett GA. Vaccination with purified microgamete antigens prevents transmission of rodent malaria. Nature. 1985 Jul 18;316(6025):258–259. [PubMed]
  • Rener J, Graves PM, Carter R, Williams JL, Burkot TR. Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum. J Exp Med. 1983 Sep 1;158(3):976–981. [PMC free article] [PubMed]
  • Vermeulen AN, Ponnudurai T, Beckers PJ, Verhave JP, Smits MA, Meuwissen JH. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J Exp Med. 1985 Nov 1;162(5):1460–1476. [PMC free article] [PubMed]
  • Targett GA. Plasmodium falciparum: natural and experimental transmission-blocking immunity. Immunol Lett. 1988 Nov;19(3):235–240. [PubMed]
  • Harte PG, Rogers NC, Targett GA. Role of T cells in preventing transmission of rodent malaria. Immunology. 1985 Sep;56(1):1–7. [PubMed]
  • Good MF, Quakyi IA, Saul A, Berzofsky JA, Carter R, Miller LH. Human T clones reactive to the sexual stages of Plasmodium falciparum malaria. High frequency of gamete-reactive T cells in peripheral blood from nonexposed donors. J Immunol. 1987 Jan 1;138(1):306–311. [PubMed]
  • Graves PM, Carter R, Burkot TR, Rener J, Kaushal DC, Williams JL. Effects of transmission-blocking monoclonal antibodies on different isolates of Plasmodium falciparum. Infect Immun. 1985 Jun;48(3):611–616. [PMC free article] [PubMed]
  • Graves PM, Wirtz RA, Carter R, Burkot TR, Looker M, Targett GA. Naturally occurring antibodies to an epitope on Plasmodium falciparum gametes detected by monoclonal antibody-based competitive enzyme-linked immunosorbent assay. Infect Immun. 1988 Nov;56(11):2818–2821. [PMC free article] [PubMed]
  • Good MF, Miller LH, Kumar S, Quakyi IA, Keister D, Adams JH, Moss B, Berzofsky JA, Carter R. Limited immunological recognition of critical malaria vaccine candidate antigens. Science. 1988 Oct 28;242(4878):574–577. [PubMed]
  • Carter R, Graves PM, Quakyi IA, Good MF. Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies. J Exp Med. 1989 Jan 1;169(1):135–147. [PMC free article] [PubMed]
  • Peiris JS, Premawansa S, Ranawaka MB, Udagama PV, Munasinghe YD, Nanayakkara MV, Gamage CP, Carter R, David PH, Mendis KN. Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria. Am J Trop Med Hyg. 1988 Jul;39(1):26–32. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press